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Abstract: The use of blenderised enteral nutrition formula (ENF) is on the increase globally. However,
concerns remain regarding the microbial quality and safety of blenderised ENF compared with
standard recommendations and commercial ENF. Aim: This was a systematic review which sought
to compare the microbial quality of blenderised ENF and commercial ENF and to evaluate the effect
of storage time on blenderised ENF. Method: Four databases (Pubmed, EMBASE, PSYCInfo and
Google scholar) were searched for relevant articles based on the Population, Intervention, Comparator,
Outcomes framework. Results: Eleven studies which met the criteria were included in the systematic
review. Two major areas were identified; Microbial Quality of Blenderised ENF versus Commercial
ENF; and The Effect of Storage Time on Microbial Quality of Blenderised ENF. Overall, 72.7% of the
studies showed microbial contamination in blenderised ENF compared with 57.1% of commercial
ENF, and the storage time was another important factor in the rates of contamination. The extent of
handling or manipulation of the enteral formula was critical in determining the level of contamination.
Conclusion: Preparation techniques for blenderised ENF need to be established and caregivers
taught how to prepare and administer it appropriately in order to reduce contamination. Further,
well-designed studies are required, which compare the microbial quality of blenderised ENF using
adequate handling techniques and commercial ENF.
Keywords: microbial quality; microbial safety; blenderised enteral nutrition formula; enteral nutrition
formula; aerobic plate count; coliform
1. Introduction
Enteral feeds are used in different clinical settings to support people who are malnourished or
unable to maintain their own nutrition, and are usually in the form of pre-packaged, ready-to-use
liquid feeds in most high-income countries [1–3]. These feeds are mostly sterile or microbial free
preparations and nutritionally complete with energy, protein, vitamins and trace elements [1,4]. In this
regard, the National Institute for Health and Care Excellence (NICE) [5] in the UK recommended
that wherever possible, pre-packaged, ready-to-use enteral feed should be used in place of feeds that
require decanting, reconstitution, and/or dilution, such as powder enteral feed, to reduce the risk of
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microbial contamination and infection. However, the use of blenderised enteral nutrition formula
(ENF), which is any whole food mixture or liquid that is blenderised to be provided through an enteral
tube and does not consist of water, medicine, or standard commercial enteral feeds, is on the increase
worldwide [6–8]. These blenderised ENFs are often made at home by blending whole food or meal
into a liquid that is thin enough to be given through a feeding tube [9,10]. Blenderised ENF can be
made exclusively of food or a combination of food and standard commercial formulas [9].
There has been an increased interest in the use of homemade blenderised ENF, which is due to the
fact caregivers and patients report a higher tolerance to real food blends, such as reduced gagging,
retching, vomiting, diarrhoea, constipation, and an overall improved maintenance of weight [11–13].
The benefits of blenderised ENF include the impact of the variety of fresh and whole foods on health,
such as the effect of phytochemicals and microbial abundance and diversity that are promoted by these
foods [11,14]. Whole food blends may be preferable to commercial formulas in selected patients and
allow the clinician and patient the ability to uniquely individualise the enteral nutrition plan [15,16].
However, there are also concerns regarding the use of these formulas due to the higher microbial load
and the increased risk of food-borne infections [17,18]. While sterile ready-to-use commercial ENF are
often associated with reduced risk of contamination and infection, it has been suggested that sterile
production of blenderised ENF will be difficult to achieve in the home setting [17]. Enteral feed is an
excellent medium for the growth and proliferation of food-borne microorganisms [19,20]. Some of the
common microorganisms found in the enteral feeding system include bacteria such as Staphylococcus
aureus and Clostridium difficile, and fungi [21,22]. In addition, other food-borne pathogens including
Salmonella enteritidis have been implicated in food-borne diarrhoea and have been associated with
enteral tube feeding [20,23].
Evidence of coliforms and fungi at unacceptable levels in blenderised ENFs has been reported [24].
There are also concerns that microbial contamination of blenderised ENF may be higher than in
commercial ENF due to issues related to contaminated ingredients and equipment, and problems with
handling and storage of the formula [9,24]. While the critical limit for the total microbial count of
enteral feed samples is 101 CFU/g at the start of feed administration, it should be 103 CFU/g at the
end [20]. For example, the U.S. Food and Drug Administration (FDA) guidelines recommend that
food products are not acceptable for consumption if the aerobic counts exceed 104 CFU/g in a single
sample; 103 CFU/g in 3 or more samples; the coliform count >3 organisms/g; and if the food products
are positive for Listeria monocytogenes or Salmonella species [25,26]. However, studies have shown
that most blenderised ENFs have standard plate counts greater than 101 CFU/g [20].
The implications of administering contaminated enteral feed and the associated infections can be
profound on patients. For example, patients who acquire an infection may develop anxiety, discomfort,
inconvenience, delayed recovery, loss of confidence in the healthcare system, increased morbidity
and mortality [19,27]. However, there have also been reports of the positive role of some microbes in
gastrointestinal health, improved gastrointestinal function and reduced enteral tube feeding intolerance
in patients fed blendersied ENF [17,24,28]. Accordingly, the enteral formula industry has responded
with many commercially-prepared whole food blends that are available in a ready to hang form [11],
although there are reported risks of food-borne diseases associated with homemade blenderised
formulas [17,24,29]. Therefore, the current review is a systematic review that aims to evaluate the
microbial quality and safety of blenderised enteral nutrition formula.
2. Methods
This review relied on the preferred reporting items for systematic reviews and meta-analyses
(PRISMA) [30].
3. Types of Studies and Samples
The studies included were cross-sectional and in-vitro experimental studies. The samples analysed
within all studies were blended ENF and commercial ENF.
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4. Inclusion and Exclusion Criteria
The inclusion and exclusion criteria were based on the Population, Intervention, Comparator,
Outcomes (PICO) framework [31] and are shown in Table 1.
Table 1. Inclusion and exclusion criteria.
Inclusion Criteria Exclusion Criteria
Population or Problem
Patients (adults) on blended tube
feeding or blenderised enteral
nutrition formula
Studies involving children aged
below 18 years
Intervention Blended enteral nutrition formula at0 h time point
Individuals on normal oral
dietary intake
Comparator
Commercial enteral nutrition formula
or Blended enteral nutrition formula





a. Microbial counts of bacteria
contamination in blenderised ENF
and commercial ENF;
b. Microbial counts of bacteria
contamination in blenderised ENF
over time.
Qualitative outcomes such as
patient feelings
Types of Study Quantitative studies Letters, comments, reviews,qualitative studies
Abbreviation: Enteral nutrition formula (ENF); hour (h).
5. Type of Intervention
Blenderised ENF, irrespective of the type of feeding tube and clinical setting, was the intervention
of interest.
6. Types of Outcome Measures
Primary Outcomes
Microbial counts of bacteria contamination in blenderised ENF and commercial ENF—aerobic
bacteria count, coliform.
Microbial counts of bacteria contamination in blenderised ENF over time.
7. Search Strategy
Pubmed, EMBASE, PSYCInfo and Google scholar were the databases searched for articles of
interest using keywords, Medical Subject Heading (MeSH)/synonyms and Boolean operators (AND/OR).
The searches were conducted from the commencement of databases until 23 July 2020. Keywords were
combined as follows; Enteral nutrition OR Blenderized formulas OR nutritional support OR home
enteral nutrition OR enteral formula OR Enteral feeding OR blenderized enteral formula OR blended
feeds OR Blenderized home-made food AND microbial contamination OR bacterial contamination.
The strategy used for searching relied on the Population or Problem, Intervention, Comparator,
Outcomes—PICO framework [31].
The process of selecting the studies included screening and evaluation for eligibility based on
the PRISMA guidelines (Figure 1) [30]. This process of selection of articles involved two researchers
(OO, OOO) who carried out the task independently, and the differences were resolved through
discussion and consensus.
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Figure 1. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow chart on
the selection and inclusion of studies.
8. Data Extraction
All the articles found in all the databases were exported to EndNote (Analytics, Philadelphia,
PA, USA) and the duplicates were removed. One researcher (OO) extracted the data from the studies
and the other four researchers (OOO, X-HW; AARA; JB) cross-checked the extracted information.
9. Evaluation of Quality
The quality of the cross-sectional study included was evaluated by one researcher (JB) using
the Joanna Briggs Institute Critical Analysis Tool [32] and cross-checked by the other researchers
(Appendix A). Only the information available in the study was used for quality evaluation.
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Table 2. Shows results of the data extracted from the studies included.
Citation Country Aim/Objective of Study Study Design Study Method/Sample Size/Description Age (Years) Study Results/Conclusion
Arias et al. [33] Costa Rica To assess the level of microbial contamination inenteral feeds in hospitals.
In-vitro
experimental study
A total of 124 enteral feeding solutions were assessed. Overall,
50% of the samples were made from commercial formula
(Ensure®) and the remaining 50% were solutions prepared at the
nutritional hospital services.
Not Applicable
The level of gram-negative bacteria in the enteral
feed samples varied from 103 to 107 CFU/mL.
Enterobacter cloacae, Escherichia coli, Serratia sp.
and Klebsiella pnuemoniae were the most
frequently isolated coliforms. Pseudomonas sp.
was isolated in more than 70% of the samples made
from commercial solutions, fruits and vegetables.
Baniardalan et al. [34] Iran To evaluate and compare the bacteria safety ofhand-made blenderised ENF and commercial ENF.
In-vitro
experimental study
Seventy samples including 21 handmade formulas sampled at two
sampling times (the time of preparation and 18 h after preparation,
and 28 commercial ENF) were studied.
Not Applicable
The microbial safety of enteral feeding solutions in
this hospital was found to be much lower than the
standard values.
Jalali et al. [20] Iran To evaluate the microbial quality of blenderizedENF in two university hospitals.
In-vitro
experimental study
A total of 152 samples (76 samples each at the time of preparation
and 18 h following preparation) were collected. Standard plate
count, coliform count and Staphylococcus aureus count in all
samples were conducted. The presence of Salmonella spp. and
Listeria spp. were also examined.
Not Applicable
It was found that most of the BTF in the hospitals
were not safe. Compared to standard levels, the
BTFs were found to be highly contaminated and
this could be a source of significant risk in the
development of food-borne disease or
nosocomial infection.
Johnson et al. [25] USA
To compare microbial levels of a standard
commercial formula (CF), a BTF made using baby




Three tube-feeding formulas (CF, BTF-BF, BTF-WF) were compared
for the growth of aerobic microorganisms, S. aureus, coliforms, and
E. coli, at zero hour, 2 h, and 4 h after tube feed preparation.
Not Applicable
It was found that BTF recipe selection and
adherence to safe food handling provide a safe
feeding that is comparable to CF in the
hospital setting.
Madden et al. [17] UK To examine the risks of blended feed in providingnutritionally adequate intake.
In-vitro
experimental study
The blended feed was made using three different methods
(professional, jug and stick blenders) and three storage procedures.
Feed samples were diluted and bacterial colony-forming units
(CFU) were counted.
Not Applicable
The level of bacterial contamination was a concern.
However, this was not due to the methods of
preparation or storage used.
Milton et al. [28] USA To examine the procedure for minimising bacterialgrowth of BTF.
In-vitro
experimental study
BTF was assessed for the growth of aerobic microorganisms
including; Escherichia coli, Staphylococcus aureus, and coliforms
at baseline, 24-h, and 48-h intervals after preparation for a total of
150 colony forming units (CFU) counts performed.
Not Applicable
It was concluded that safe food-handling
procedures can reduce bacterial contamination of
BTF and can also reduce the risk of food-borne
infection in HEN patients.
Mahinkazemi et al. [29] Iran To examine bacterial contaminations of enteralfeeding (EF).
In-vitro
experimental study
A total of 54 EF samples; 36 blenderised tube feedings (BTFs) and
18 commercial powder feedings (CPFs) of patients in the intensive
care units were examined.
Not Applicable
The issues of quality, safety, and the appropriate
type of enteral nutrition formulas are essential
based on the bacterial contamination of CPFs.
Mokhalalati et al. [35] SaudiArabia
To compare the microbial safety of BTF and
commercially prepared formulas (CPF).
In-vitro
experimental study
Eighteen samples of BTF were collected from 3 hospitals.
Samples of a CPF were also collected for comparison. Not Applicable
BTFs are highly contaminated and may increase the
risk of nosocomial infections.
Pinto et al. [36] Brazil
To assess the microbiological quality and aseptic
conditions in the preparation and administration of
handmade and commercial ENF.
In-vitro
experimental study
Twenty-five samples of enteral diets were analysed, 13 of them
were non-industrialized diets (prepared in the hospital facility)
and 12 were industrialized diets, collected in two different times
(immediately after the completion preparation (T0) and after
administration to the patient (T1). There were 50 sample units,
each of them containing at least100 mL of the diet.
Not Applicable
The microbial quality of the enteral feeds was not
satisfactory. The aseptic conditions in the hospital
concerning preparation and handling of enteral
diets increases the risks of cross-contamination.
Sullivan et al. [37] Philippines To assess the microbial quality of BTF. In-vitroexperimental study
Two feedings were prepared on three separate days at four
hospitals. The tube feedings were either blended foods or
commercial products. Samples of each feeding were collected for
coliform count and standard plate count at the time of preparation
and different times after preparation.
Not Applicable
The microbial quality of most of the
hospital-prepared enteral tube feedings was not
within the published guidelines for microbial safety.
Vieira et al. [38] Brazil To evaluate the microbial quality of commercialENF and blenderised whole foods ENF.
Cross-sectional
study
A total of 66 samples of commercial (CD, n = 33) and
noncommercial (NCD, n = 33) enteral diets were collected at the
homes of patients on HEN.
73 years
(20–100 years)
The homemade blenderised ENF contained high
levels of bacterial contamination.
Abbreviations: Blenderised tube diets (BTD); blenderized tube feeding (BTF); Colony forming units (CFU); home enteral nutrition (HEN); home enteral tube feeding (HETF).
Int. J. Environ. Res. Public Health 2020, 17, 9563 6 of 12
10. Results
Three studies out of the eleven studies included were conducted in Iran [20,29,34] and two in the
USA [25,28] (Table 2). In addition, two other studies were conducted in Brazil [36,38], and one study
each in Costa Rica [33], the Philippines [37], Saudi Arabia [35] and the UK [17].
There were two distinct areas identified, namely: Microbial Quality of Blenderised ENF versus
Commercial ENF; The Effect of Storage Time on Microbial Quality of Blenderised ENF.
10.1. The Effect of Storage Time on Microbial Quality of Blenderised ENF
Johnson et al. [25] found that there was no S.aureus or coliform/E.coli detected at any time point
following preparation. Furthermore, the total bacterial count was well below acceptable limits and
all feeding formulas were acceptable for human consumption [25]. Reports from Madden et al. [17],
Milton et al. [28] and Mahinkazemi et al. [29] were similar. While Madden et al. [17] showed that the
impact of storage time on bacterial colony-forming units (CFU) varied with an increase in colonies on
some agars but, overall, was not significantly different (feed A, p = 0.091; B, p = 0.764; C, p = 0.263),
Milton et al. [28] observed that no sample had zero aerobic microbial counts although no substantial
increase in microbial counts was observed during the 48 h. On the other hand, Mahinkazemi et al. [29]
found that bacterial contamination (S. aureus, coliform) of blenderised tube feeding at the preparation
time and 18 hrs after preparation did not change.
However, Baniardalan et al. [34] reported that the difference between the total viable contamination
of the first and second sampling of blenderised ENF was significant (p = 0.004). In particular, after 18 h
of preparation of the blenderised ENF, the coliform contamination increased by about 1.5 logs (p = 0.085)
and S. aureus contamination also increased by about 2 logs (p = 0.008). In the Jalali et al. [20] study,
there were significant increases in bacteria counts (coliform and S. aureus) 18 h after food preparation
(p-value < 0.001).
Similarly, Mokhalalati et al. [35] demonstrated that there were significant increases over time in
aerobic plate counts (APC) at each site (site 1, p = 0.023; site 2, p = 0.006; site 3, p = 0.042), and that for
all blenderised tube feeding combined, there were significant increases in APC over time (p < 0.0005).
Sullivan et al. [37] also found that the mean standard plate counts and mean coliform counts for
blenderised samples taken immediately after tube feeding preparation increased significantly over
time: (p = 0.008) and (p = 0.0005), respectively.
10.2. Microbial Quality of Blenderised ENF versus Commercial ENF
Table 3 shows the summary of results of the level of microbial contamination of blenderised ENF
compared with commercial ENF and/or international standards. In the study by Mahinkazemi et al. [29],
it was observed that the total coliforms of blenderised ENFs were less than 2 Most Probable Number
(MPN)/g at both times. In contrast, six samples out of 18 (33%) commercial ENFs (powders) that
were prepared on the wards were contaminated by coliform (6.41 ± 2.43 MPN/g), and E. coli was
detected [29]. However, S. aureus, Salmonella and L. monocytogenes were not detected in either enteral
formulas [23]. Baniardalan et al. [34] also found that the contamination of commercial ENF in all
the samples was significantly (p < 0.05) more than that of the blenderised ENF. However, both the
blenderised and commercial ENF were not contaminated with Salmonella spp. and L. monocytogenes.
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Table 3. Summary of results of the level of microbial contamination of blenderised ENF compared with commercial ENF and/or international standards.
Citation Level of Microbial Contamination ofBlenderised ENF
Level of Microbial Contamination
of Commercial ENF Comments
Arias et al. [33] ↑ ↑
The concentration of gram negative rods found in the samples of enteral feeding solutions
ranged from 103 to 107 CFU/mL, significantly exceeding the permissible level (102 CFU/mL or
less). There were no differences in the levels of contamination of the formulas. Blenderised
ENF made from fruits or cooked vegetables showed contamination levels as high as the ones
present in the commercial based solutions (Ensure®).
Baniardalan et al. [34] ↑ ↑
The contamination of commercial formulas in all three microbiological samples was
significantly more than that for handmade samples. Overall, 76% of handmade samples had
total viable counts greater than 103 CFU/g compared to 96% of commercial formulas at the time
of preparation.
Jalali et al. [20] ↑ Not Applicable In the standard plate count, 97% of the samples had counts greater than 10
3 CFU/g, while 71%
had counts greater than 104 CFU/g at the time of preparation.
Johnson et al. [25] Total bacterial count was well belowacceptable limits
Total bacterial count was well below
acceptable limits
All 3 feeding formulas at zero hour, 2 h, and 4 h for each of the 3 sampling dates were
acceptable for human consumption.
Madden et al. [17] ↑ Not Applicable
The bacterial load of Enterobacteriaceae of approximately half of the blended feeds was
categorised as unsatisfactory (i.e., CFU/g > 104), with no clear pattern of association with
preparation or storage method.
Milton et al. [28]
At time of preparation and after 24 h,
10% had a CFU count of >104, and, at 48 h,
12% exceeded 104 CFUs.
Not Applicable
The result showed that 88% of the samples met the US Food Code criteria for safe food
consumption; 10.7% met guidelines for marginal safety by other standards; and 1.3% slightly
exceeded 105 CFUs.
Mahinkazemi et al. [29]
Bacterial contamination (S. aureus, coliform)
of blenderised ENF at the time of
preparation and 18 h after preparation were
<101 CFU and <2 MPN/g, respectively.
Overall, 33% of commercial ENF
which were prepared in the wards
had coliform contamination of 6.41 ±
2.43 MPN/g and E. coli was detected.
The presence of E. coli and coliforms in 33.3% of commercial ENF showed that these were at an
unacceptable level of contamination.
Mokhalalati et al. [35] ↑ ↓
Overall, 86% of standard blenderised ENF and therapeutic blenderised ENF had Aerobic Plate
Count (APC) >104 CFU/g, while for all commercial ENFs, APC was not detectable (<10 CFU/g)
at all times. The maximum coliform count for any blenderised ENF sample from sites 1 and 2
was 50 CFU/g. Coliform counts for all Commercial ENFs were non detectable (<10 CFU/g).
Pinto et al. [36] ↑ ↑
Both kinds of blenderised ENF and commercial ENF showed contamination by coliforms and
Pseudomonas spp. Listeria spp. was detected in only one sample of handmade diets. However,
contamination was significantly higher in the blenderised ENF (p < 0.05) compared with
Commercial ENF.
Sullivan et al. [37] ↑ Not Applicable
Overall, 38% of blenderised ENF had coliform counts greater than 10 MPN/g, and 92% of the
samples had standard plate counts greater than 103 CFU/g. There were significant increases in
mean coliform and standard plate counts over 4 h.
Vieira et al. [38] ↑
Samples of powder commercial ENF
complied less when compared to
liquid commercial ENF.
Only 6% of samples of blenderised ENF met the standard for coliform.
Abbreviations/Symbols: Colony forming units (CFU); enteral nutrition formula (ENF); most probable number (MPN); high level of contamination (↑); low or non-detectable level of
contamination (↓).
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In contrast, Sullivan et al. [37] noted that the natural food provided significantly higher mean
standard plate counts than the commercial powder formula feeds at 1 and 2 h after preparation. This is
supported by Vieira et al. [38], who also found that the counts of mesophilic and coliform bacteria
were significantly higher in the non-commercial enteral diet and only 6.0% of the samples complied
with the standard for coliform bacteria. Mokhalalati et al. [35] reported that the aerobic plate counts
for all commercial ENF were not detectable (<10 cfu/g) at all times. Additionally, while the maximum
coliform count for any blenderised ENF sample from sites 1 and 2 was 50 cfu/g, the coliform counts
for all commercial ENF were not detectable (<10 cfu/g) [35]. However, all the blenderised ENF and
commercial ENF samples were negative for Salmonella and Staphylococcus aureus (<10 cfu/g) [35].
In the study by Pinto et al. [36], the two types of enteral feeds showed contamination by coliforms
and Pseudomonas spp. although there was no positive sample for Staphylococcus aureus and
Salmonella spp. However, Listeria spp. was found in only one sample of handmade diets and the level
of contamination was significantly higher in the handmade preparations (p < 0.05) [36]. Arias et al. [33]
found that the degree of manipulation did not affect the microbial quality of blenderised ENF and that
the level of contamination was as high as that in the commercial ENFs. Similarly, Johnson et al. [25]
reported that the recipe selection and adherence to safe food handling of blenderised ENF provided
safe feeding that was comparable to commercial ENF.
11. Discussion
The results of the studies included in this review showed varied outcomes in terms of the levels
of bacterial contamination of blenderised ENF compared with commercial ENF. Similarly, the impact
of storage time on bacterial colony-forming units of blenderised ENF differed between the studies.
While some of the studies found that the increases in bacteria counts over time were not significant,
the others demonstrated a significant increase.
However, eight of the eleven studies included, representing a proportion of 72.7%, reported
that the level of microbial contamination of blenderised ENF was either a concern, higher than or
not within the standard of international guidelines [17,20,33–38], compared to commercial ENF with
four [29,33,34,36] out of seven studies (representing 57.1%). The differences between blendersied ENF
and commercial ENF with respect to bacteria counts in this review may be due to a range of factors.
For example, it has been suggested that microbial contamination in blenderised ENF may result from
multiple phases including contaminated ingredients and equipment used for the blenderised ENF,
poor hand hygiene, and storage and distribution processes that encourage microbial proliferation [24].
Borghi et al. [24] revealed there was 30–90% contamination in the open system of blenderised ENF
and it was found to be associated with poor aseptic technique, poor cleaning and disinfection of
equipment and ingredients that were contaminated. Madden et al. [17] also reported that the microbial
loads of blenderised ENF are inevitable when the formulas are made from non-sterile ingredients and
non-sterile conditions such as work surfaces, jugs, blenders and sieves, which are potential sources for
microbial contamination. In the study by Mokhalalati et al. [35], almost all the blenderised ENFs had
aerobic plate counts that were greater than 10,000 cfu/g compared with counts of less than 10 cfu/g
(the detection limit) for all samples of commercial feeds.
According to Jalali et al. [20], 75% to 96% of blenderised tube feeding samples in the Philippines
had standard plate counts that were greater than 101 cfu/g, while higher contamination of blenderised
ENFs was found in Saudi Arabia. Furthermore, almost all the samples of blenderised ENF studied in
Saudi Arabia were reported to have aerobic plate counts greater than 104 cfu/g [20]. Jalali et al. [20]
noted this is particularly important as the Food and Drug Administration (FDA) has recommended
that medical foods including enteral feeding formulas, containing more than 104 cfu/g or if three or
more samples exceed 103 cfu/g, would require further action to be taken.
Another area of interest is that some of the commercial ENFs examined in the studies in the current
review included powder or commercial liquid formulas, which required different levels of handling,
and these were compared with blenderised ENF. This element may explain why the results were
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not significantly different between the blenderised ENF and commercial ENF in some of the studies.
According to Vieira et al. [38], the greater the need to handle enteral feeding formula, the higher the
risk of microbial contamination. In particular, the level of microbial contamination decreases with
the progression from blenderised ENF, which may be highly manipulated, to commercial powder
formulas, and from commercial liquid formulas in cans to commercial formulas delivered in closed
enteral feeding systems [35]. It has been reported that non-commercial and powdered commercial
formula (which require decanting and reconstitution) show higher levels of microbial counts and lesser
compliance with standards than the liquid commercial formula [38]. This is due to the procedure used
for the non-commercial formulas (blenderised) such as inadequate cooking of contaminated raw foods
and cross-contamination from food handlers and equipment, and the handling and hydration of the
powder commercial formula, which are not required for the liquid commercial formula [38].
In terms of the effect of storage time on blenderised ENF, there is evidence that enteral feed,
whether blenderised or commercial, provides an excellent medium for the growth of food-borne
micro-organisms, which are of public health significance [20]. Furthermore, the contamination of
enteral feed increases the risk of nosocomial infections including diarrhoea and pneumonia [20].
Therefore, strategies for reducing microbial contamination of enteral feeding formulas need to be
developed to reduce the risk of microbial contamination. For blenderised ENF, preparation techniques
need to be established and caregivers taught how to prepare and administer ENF appropriately to
reduce contamination. In addition, cleaning and sanitizing of kitchen equipment and surfaces needs
to be embedded in the preparation of blenderised ENF [28]. Appropriate blenders and equipment
need to be cleaned thoroughly through disassembling and effective sanitisation, alongside the need to
ensure adequate home environments including water source, refrigeration temperature and storage
capacity for blenderised ENF [28]. Brown et al. [9], acknowledged that food safety is a concern in
blenderised ENF; therefore, it is essential that the foods are cooked thoroughly, and are kept at the
correct temperature. It has also been recommended that blenderised ENF should be administered
in the form of bolus feed instead of continuous infusion [9]; this supports its safe administration,
rather than allowing the blenderised ENF to be at room temperature for more than 2 h [9].
Furthermore, recommendations for the use of sterile (commercial) ENF have been made when
there is a risk of aerobic counts of non-sterile feeds [37,39]. For example, NICE [5] recommended that
wherever possible, pre-packaged, ready to use feeds should be used instead of feeds that would be
decanted, reconstituted or diluted, such as the powdered commercial formulas. In addition, the system
selected should allow for minimal handling to assemble and should be compatible with the patients’
enteral feeding tube [5]. Therefore, sterile, non-manipulated closed systems of enteral nutrition
administration, good hygiene and maintaining microbial surveillance are the preferred approaches to
reducing microbial contamination and managing enteral nutrition provision [40].
12. Limitations
Most of the blenderised ENF microbial studies were conducted in countries and conditions
where the ambient temperatures are higher than those expected in hospitals and homes of developed
countries. In addition, the methods of blenderised ENF preparation in those studies were not well
described; therefore, it may be difficult to ascertain whether they were prepared properly. Many of
the studies were conducted a few years ago and storage and refrigeration techniques could also have
skewed the results.
13. Conclusions
This systematic review has demonstrated there are significantly higher levels of bacteria
contamination in blenderised ENF compared with commercial formula. Furthermore, there are also
differences in terms of the level of bacteria contamination between blenderised ENF and commercial
formula based on storage time. Therefore, preparation techniques for blenderised ENF need to
be established and caregivers taught how to prepare and administer it appropriately to reduce
Int. J. Environ. Res. Public Health 2020, 17, 9563 10 of 12
contamination. More well-designed studies comparing the microbial quality of blenderised ENF using
adequate handling techniques and commercial ENF are required. Furthermore, it will be useful for
future studies to explore the effect of poor handling of ENF on health outcomes.
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Appendix A
Table A1. Joanna Briggs Institute Critical Analysis Tool for Cross-sectional Studies.
Vieira et al., 2016
1. Were the criteria for inclusion in the sample clearly defined? YES
2. Were the study subjects and the setting described in detail? YES—commercial andnon-commercial enteral feeds
3. Was the exposure measured in a valid and reliable way? NOT APPLICABLE
4. Were objective, standard criteria used for measurement of the condition? YES
5. Were confounding factors identified? NO
6. Were strategies to deal with confounding factors stated? NOT APPLICABLE
7. Were the outcomes measured in a valid and reliable way? YES
8. Was an appropriate statistical analysis used? YES
Note: The authors could not find quality assessment tools for the in-vitro studies.
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